California M-License Operators in a Bifurcated Federal World: A Legal Deep Dive on DOJ’s April 2026 Rescheduling Order
by The Law Office of Shay Aaron Gilmore On April 22, 2026, Acting Attorney General Todd Blanche signed the most consequential federal cannabis order in more than five decades. The order immediately moves both FDA-approved cannabis products and state-regulated medical cannabis products from Schedule I to Schedule III of the Controlled Substances Act (CSA). At …